Related Experiment Video
Updated: Jul 14, 2026
15:43
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
[C3 complement polymorphism in patients suffering from obstructive chronic bronchopneumopathy in Tunisia]
N Leban1, A Haj Khelil, H Daimi
1Laboratoire de biochimie et de biologie moléculaire, Faculté de pharmacie, Monastir, Tunisia.
Annales De Biologie Clinique
|May 16, 2007
Summary
This study investigated the C3*S and C3*F polymorphism in obstructive chronic bronchopneumopathy (OCBP) patients. No significant correlation was found between C3 gene variants and the risk of developing OCBP.
Area of Science:
- Immunogenetics
- Pulmonary Medicine
Context:
- The third component of complement (C3) plays a crucial role in immune responses.
- Obstructive chronic bronchopneumopathy (OCBP) is a significant respiratory condition with complex etiology.
- Understanding genetic predispositions like C3 polymorphism may offer insights into disease risk.
Purpose:
- To analyze the C3*S and C3*F polymorphism at both protein and gene levels.
- To determine the phenotypic and genotypic frequencies of C3 in Tunisian OCBP patients and healthy controls.
- To investigate a potential correlation between C3 polymorphism and OCBP susceptibility.
Summary:
- C3 polymorphism was assessed in 90 OCBP patients and 437 healthy controls using electrophoresis and ARMS PCR.
- Allele frequencies for C3*S and C3*F in OCBP patients were 0.788 and 0.212, respectively.
- These frequencies did not significantly differ from control group values (0.834 and 0.152), indicating no association.
Impact:
- This research suggests that C3*S and C3*F polymorphism are not associated with the risk of developing obstructive chronic bronchopneumopathy in the Tunisian population.
- Findings contribute to the understanding of genetic factors in respiratory diseases.
- Further research may explore other genetic markers or environmental factors in OCBP etiology.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...